EverSource Wealth Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.9K Buy
1,799
+583
+48% +$13.3K ﹤0.01% 1978
2026
Q1
$26.8K Sell
1,216
-150
-11% -$2.61K ﹤0.01% 2319
2025
Q4
$16.1K Buy
1,366
+979
+253% +$12.6K ﹤0.01% 2529
2025
Q3
$6.13K Buy
387
+199
+106% +$2.89K ﹤0.01% 3068
2025
Q2
$2.16K Sell
188
-468
-71% -$5.27K ﹤0.01% 3488
2025
Q1
$8.88K Buy
656
+335
+104% +$5.56K ﹤0.01% 2171
2024
Q4
$5.43K Buy
321
+30
+10% +$584 ﹤0.01% 2303
2024
Q3
$5.92K Buy
291
+76
+35% +$1.55K ﹤0.01% 2155
2024
Q2
$5.19K Buy
215
+5
+2% +$131 ﹤0.01% 2212
2024
Q1
$5.63K Buy
210
+12
+6% +$342 ﹤0.01% 1994
2023
Q4
$6.25K Buy
198
+48
+32% +$1.3K ﹤0.01% 1767
2023
Q3
$4.21K Sell
150
-600
-80% -$20.6K ﹤0.01% 1769
2023
Q2
$27.7K Buy
750
+736
+5,257% +$22.5K ﹤0.01% 1032
2023
Q1
$419 Buy
+14
New +$461 ﹤0.01% 2263

Other funds holding CC

EverSource Wealth Advisors's CC Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Chemours (CC) stake by 48% in Q2 2026, buying an estimated $13.3K and bringing the position to 1,799 shares worth $36.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1978.

EverSource Wealth Advisors first reported a position in CC in Q1 2023 and has held it in 14 quarters since. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • EverSource Wealth Advisors held 1,799 shares of Chemours worth $36.9K as of Q2 2026.
  • EverSource Wealth Advisors bought 583 Chemours shares in Q2 2026, an estimated $13.3K.
  • Chemours made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1978 holding.
  • EverSource Wealth Advisors first reported a position in Chemours in Q1 2023 and has held it in 14 quarters since.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.